10h45 – 12h30Establish draft recommendations based on quality of the evidence, balance between desirable and undesirable effects, resources, feasibility, values and preferences.All
12h30 -13h30Lunch
13h30 – 15h30Review recommendations as a whole (continued), including conditions associated with potential recommendations.
Completes decision grid and determine the strength of recommendation.		All
15h30 – 16h00Tea break
16h00 – 16h30Recommendation for further data and future research, including on various populations (PLHIV, children, other)All
16h30 – 17h30Recap and review of final recommendationsAll
17h30 – 18h00Next steps, implementation and ConclusionDiana Weil/Karin Weyer
18h00Adjourn

From: Annex 3, Expert Group meeting on interim guidance for the use of delamanid in the treatment of multidrug-resistant tuberculosis

Cover of The Use of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis
The Use of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance.
Copyright © World Health Organization 2014.

All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob).

Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html).

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.